Rapport d’analyse de la taille, de la part et des tendances du marché mondial de la pathologie numérique – Aperçu et prévisions de l’industrie jusqu’en 2031

Analyse du marché de la pathologie numérique

L'utilisation de cette technologie disruptive est sur le point de devenir la norme de soins dans le domaine de la pathologie. Des images statiques, des images en streaming en direct et, plus récemment, l'imagerie de lames entières ont toutes été utilisées en pathologie numérique (WSI). Les appareils de pathologie numérique ou les algorithmes d'analyse d'images utilisés dans les rapports de diagnostic nécessitent généralement une approbation réglementaire telle que la FDA (USA) ou CE IVD. La pathologie numérique et l'analyse d'images pourraient améliorer la précision, la reproductibilité et la standardisation des critères d'inclusion et des résultats des études.

Taille du marché de la pathologie numérique

La taille du marché mondial de la pathologie numérique a été évaluée à 1,22 milliard USD en 2023 et devrait atteindre 3,15 milliards USD d'ici 2031, avec un TCAC de 12,5 % au cours de la période de prévision de 2024 à 2031.

Portée du rapport et segmentation du marché       

Digital Pathology Market Definition

Digital pathology is the practice of pathology that employs digital imaging. Digital pathology is the use of computer workstations to view digital whole slide images (WSIs) obtained from high resolution scanning of glass microscope slides applications include teaching, research and primary diagnostic reporting.

Digital Pathology Market Dynamics

Drivers

• Rapid Technological Advancements are Fostering the Market Growth

Rapid technological advancements in digital pathology systems are also expected to drive market expansion. Digital imaging, computerization, robotic light microscopy, and multiple fibre optic communications are all contributing to the expansion. Whole slide imaging is one such technique that has several advantages over conventional light microscopes and is expected to boost the market.

• Rising use of AI in Healthcare

The use of AI in healthcare is increasing, with a growing emphasis on improving patient care quality by incorporating AI into various aspects of healthcare services, such as pathological diagnosis. As a result, artificial intelligence (AI) provides smooth primary care flow and automation, allowing doctors to focus on more essential and horrific patients. Furthermore, AI solutions in the healthcare industry are becoming more humanized.

Opportunities

• Growing Preference for Computer-Aided Diagnosis

The growing preference for computer-aided diagnosis, which integrates image processing, physics, mathematics, and computing algorithms, enables efficient disease detection, and aids in the evaluation of anatomic structures of interest, as well as the quantification of disease progression and risk assessment, will drive market growth. Companies such as Olympus are providing a variety of tools for remote slide sharing and image processing, which is expected to drive market growth in the coming years. Leica Biosystems received FDA approval for the Aperio AT2 DX Scanner and Aperio WebViewer for remote diagnosis during the pandemic in April 2020. During this emergency, Phillips also received FDA approval for its IntelliSite Pathology Solution for remote diagnosis.

Restraints/Challenges

• High Cost of Digital Pathology

High cost of digital pathology and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. Augmenting keeps the cost of digital pathology low by functioning as a modular hardware platform with integrated digital pathology software applications.

This digital pathology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the digital pathology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Digital Pathology Market

The COVID-19 pandemic had a significant impact on digital pathology services. Digital pathology has the potential to "protect clinical services and pathology-based research in the current and future climates. This digital-based diagnostic approach represents a new approach to evaluating surgical pathology slides from formalin-fixed paraffin-embedded tissue (FFPE). It liberates the pathologist from the constraints of working with an optical microscope in his or her office. At the same time, it can have an impact on pathologists “social interaction,' including their interactions with clinicians and even patients. At the peak of the COVID-19 pandemic, a recent contribution from our group briefly addressed the changing aspects of such a relationship.

Digital Pathology Market Scope

The digital pathology market is segmented on the basis of type, product, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Human Pathology
• Veterinary Pathology

Product 

• Scanners
• Brightfield
• Other Scanners
• Software
• Integrated software
• Standalone software
• Storage Solution

Application 

• Drug Discovery
• Disease Diagnosis
• Training and Education

End users

• Academic and Research Institutes
• Hospitals and Reference Laboratories
• Pharmaceutical and Biotechnology Companies

Digital Pathology Market Regional Analysis

The digital pathology market is analyzed and market size insights and trends are provided by country, type, product, application and end users as referenced above.

The countries covered in the digital pathology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the digital pathology market due to introduction of favorable reimbursement policies and the implementation of favorable initiatives by the government in the U.S. and Canada.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2024 to 2031 owing to the rising prevalence of cancer diseases in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Digital Pathology Market Share

The digital pathology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital pathology market.

Digital Pathology Market Leaders Operating in the Market Are:

• F. Hoffmann-La Roche Ltd (Switzerland)
• Hamamatsu Photonics (Japan)
• 3DHISTECH Ltd. (Hungary)
• AstraZeneca (U.K.)
• General Electric (U.S.)
• Healthcare Trading Co. LLC (UAE)
• Koninklijke Philips N.V (Netherlands)
• Inspirata, Inc. (U.S.)
• Olympus Corporation (Japan)
• Sectra AB (U.S.), PerkinElmer Inc. (U.S.)
• Apollo Enterprise Imaging Corp (U.S.)
• Mikroscan Technologies, Inc. (U.S.)
• VMscope GmbH (Germany)
• Huron Technologies International Inc. (Canada)
• Objective Pathology Services Limited (Canada)
• OptraScan (U.S.)
• Pathcore (Canada)
• Agfa-Gevaert Group (Belgium)
• Proscia Inc. (U.S.)

Latest Developments in Digital Pathology Market

• En septembre 2021, Visiopharm (Danemark) et Agilent Technologies, Inc. (États-Unis) ont collaboré pour commercialiser conjointement le portefeuille de logiciels de pathologie de précision pilotés par l'IA marqués CE-IVD de Visiopharm et le portefeuille de solutions automatisées de coloration de pathologie d'Agilent. S'appuyant sur une vision commune de la qualité de bout en bout et de la standardisation des diagnostics tissulaires, l'alliance répondra aux besoins non satisfaits des laboratoires de pathologie du monde entier. L'objectif commun des entreprises est de créer une technologie, des produits et des services qui amélioreront l'uniformité des laboratoires de pathologie et accéléreront le diagnostic correct
• En avril 2021, OptraSCAN a lancé les scanners haute vitesse OS-Ultra 320. L'appareil est conçu pour numériser des cellules/tissus de 15 x 15 mm avec un grossissement de 40 x en 60 secondes. De plus, l'utilisation généralisée des scanners dans les laboratoires de pathologie propulse la croissance du marché

SKU-18718